NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

This is all very cool, if not old, information. When will the srock finally move

When 8 hedges have finished spoofing the share price and starts covering their counterfitted shares?

As I informed you about twice, in case you missed the information regarding the litigation and the quality of the evidence gathered for the lawsuit:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171185839

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171203109

It's not as if NWBO is hibernating regarding working against milestones. Whether or not reaching these can get hedges to stop their doings, probably depends on how much an impact it will have.

Let's look at next potential milestone. Next Tuesday February 28th. The APPGBY groups "PATHWAY TO A CURE" report to be announced in Westminster.

What has happened in the UK the last year?

1) Dr Marnix Bosch spoke at the BTNW Annual Retreat 2022, Wednesday 2nd March to an english crowd of gmb clinicians. Hush hush.

2) Liau in England of the week before May 5th 2022 presentation. Hush hush.

3) DCVax-L promoted in oral sessions in the APPGBT group. A focal point for the group is COST!!!! And while cost of DCvax-L seems to have been dropping from $250K to $185K and automation assumably will be able to drop cost further, the competitor - according to these oral sessions - NVCR and their Optune device, while they also have spoken at the APPGBY meetings, is still expensive. And NOT NICE approved for reimbursement. Optune still doesn't treat anything. It MIGHT keep cancer cells inactive for some months, while patient must wear a device 18 hours each day on a bald head. While DCvax actually TREATS. Heals. Non toxic.

4) DCVax-L first PIM in the UK

5) Point of Market framework in the UK.

https://www.gov.uk/government/consultations/point-of-care-consultation/consultation-on-point-of-care-manufacturing

Cell therapy biotechs look to UK.

https://endpts.com/instil-bio-cell-therapy-shifts-focus-to-uk-us-layoffs/

6) British politicians KNOWS, DCvax-L in combos will have astounding efficacy. Between 50-65% currently against gbm

This is not just about DCvax-L and NWBO.

It is about being first to market in cell immunotherapy regarding automation. It's about creating jobs at Advent and shift focus even further from the US.

There's nothing but great info about Advent here

https://cgt.ams3.cdn.digitaloceanspaces.com/Manufacturing-Report-Final.pdf

Again. I can not believe otherwise, that the 28th. is a focal point for NWBO and I can't see a better day to get further info regarding MIA approval or MAA submission/approval. It should be able to gain some much needed attention.